| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,366 |
7,896 |
$265K |
| 99490 |
Ccm add 20min |
6,638 |
4,961 |
$117K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,110 |
12,726 |
$64K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,649 |
1,209 |
$63K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
920 |
485 |
$57K |
| 99497 |
|
1,453 |
1,093 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
352 |
298 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
12,087 |
7,196 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
174 |
156 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
195 |
103 |
$4K |
| 86328 |
|
64 |
58 |
$3K |
| 96367 |
|
112 |
52 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,348 |
764 |
$2K |
| 96417 |
|
49 |
24 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
13 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
79 |
37 |
$403.54 |
| 99406 |
|
81 |
52 |
$402.96 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
234 |
116 |
$260.84 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
228 |
117 |
$194.08 |
| 80053 |
Comprehensive metabolic panel |
15 |
14 |
$123.42 |
| 99072 |
|
489 |
360 |
$26.78 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
25 |
12 |
$22.81 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
40 |
24 |
$22.24 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,410 |
1,856 |
$0.52 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
690 |
522 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
323 |
243 |
$0.00 |
| 1124F |
|
137 |
107 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
63 |
32 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
27 |
12 |
$0.00 |
| 4040F |
|
25 |
12 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
26 |
12 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
596 |
460 |
$0.00 |
| 1036F |
|
322 |
236 |
$0.00 |